D. E. Shaw & Co., Inc. Arrowhead Pharmaceuticals, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	BUY	$20.56 - $63.12 $34,952 - $107,304	1,700 Added 11.26%	16,800 $483,000
Q4 2019 Feb 14, 2020	BUY	$28.14 - $73.01 $191,352 - $496,468	6,800 Added 81.93%	15,100 $958,000
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $144,669 - $239,206	8,300 New	8,300 $220,000

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.99B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.